NCT02371980 Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder (MDD) Status COMPLETED Phase PHASE4
NCT02369393 Efficacy of Two Internet Delivered Intervention Programs for Depression: Behavioral Activation vs Physical Activity Status COMPLETED Phase NA
NCT02366364 Study of Safety, Tolerability and Pharmacokinetics of NRX-1074 in Normal Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02362529 Biomarkers of Neuroinflammation and Anti-Inflammatory Treatments in Major Depressive Disorder Status COMPLETED Phase EARLY_PHASE1
NCT02361684 e-Compared-S: Comparative Effectiveness Research on Internet-based Depression Treatment - Spanish Trial Status COMPLETED Phase NA
NCT02356107 5-hydroxytryptophan and Creatine for Treatment Resistant Depression Associated With Hypoxia in Females Status COMPLETED Phase PHASE4
NCT02339285 Transcranial Alternating Current Stimulation for Major Depressive Disorder Status COMPLETED Phase NA
NCT02334228 Evaluation of the In SHAPE Fitness Intervention for Adults With Serious Mental Illness Status COMPLETED Phase NA
NCT02332954 Assessment in Work Productivity and the Relationship With Cognitive Symptoms in Patients With MDD Taking Vortioxetine Status COMPLETED Phase PHASE4
NCT02330679 Prediction of Antidepressant Treatment Response Using Machine Learning Classification Analysis Status UNKNOWN Phase PHASE4
NCT02311725 Storytelling Video Intervention for Depressed Primary Care Patients - Pilot Trial Status COMPLETED Phase NA
NCT02309060 Storytelling Video Intervention for Depressed Primary Care Patients - Open Trial Status COMPLETED Phase NA
NCT02308956 Task Sharing for the Care of Severe Mental Disorders in a Low-income Country Status COMPLETED Phase PHASE3
NCT02294305 Vortioxetine Versus Placebo in Major Depressive Disorder Comorbid With Social Anxiety Disorder Status UNKNOWN Phase PHASE4
NCT02285608 Partnership in Medication Management (PIMM) in Patients With Mood Disorders Status UNKNOWN Phase NA